GR2001 Injection

· Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GR2001 Injection, covering 2024-10-10 to 2024-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection [Phase 3]

See pricing